Marex Group Tidigare resultatutveckling
Tidigare kriterier kontrolleras 5/6
Marex Group har ökat intäkterna med en genomsnittlig årlig takt på 34.9%, medan Capital Markets -branschen såg intäkterna växer på 6.3% årligen. Intäkterna har varit växande med en genomsnittlig takt på 25.8% per år. Marex Group s avkastning på eget kapital är 25.8% och den har en nettomarginal på 10.2%.
Viktig information
34.90%
Tillväxttakt i vinsten
38.58%
Tillväxttakt för EPS
| Capital Markets Tillväxt i branschen | 10.26% |
| Intäkternas tillväxttakt | 25.76% |
| Avkastning på eget kapital | 25.82% |
| Nettomarginal | 10.22% |
| Senaste uppdateringen av resultatet | 31 Mar 2026 |
Senaste uppdateringar av tidigare prestationer
Recent updates
Uppdatering av berättelse • Jun 05
MRX: Levmet Deal And Bermuda Move Will Support Measured Future Upside
Analysts have maintained their $57.13 price target for Marex Group, reflecting steady assumptions for its discount rate, an expected revenue decline of 7.25%, a profit margin of 20.12% and a future P/E of 11.49x. What's in the News Marex Group agreed to acquire Levmet, a Monaco based liquidity provider focused on base and ferrous metals, energy, and power.Uppdatering av berättelse • May 22
MRX: Q1 2026 Guidance And Dividend Outlook Will Support Measured Upside
Analysts have raised their price target for Marex Group from $55.00 to $57.13, citing updated assumptions on revenue trends, profit margins and future P/E expectations. What's in the News Marex Group plc issued earnings guidance for the first quarter of 2026, with expected revenue in a range of $667 million to $697 million for the period ended March 31, 2026, compared with Q1 2025 revenue of $467 million (Key Developments).Seeking Alpha • May 20
Marex Group: Strong Growth, Cheap Valuation, But Still A Volatility-Driven Story
Summary Marex Group plc (MRX) delivered strong Q1 results, with revenues up 48% and adjusted profit before tax up 59%, driven by volatility in energy and metals. MRX's forward P/E of 11.5x and high 22.1% operating margin position it attractively versus peers, despite a cyclical, volatility-dependent business model. Revenue diversification into clearing, securities, and solutions segments reduces reliance on commodities, but future growth remains sensitive to macroeconomic cycles. Key risks include interest rate declines, slower client balance growth, integration of WEBB Traders, and potential operational disruptions from the Bermuda headquarters move. Read the full article on Seeking AlphaUppdatering av berättelse • May 07
MRX: Higher Margins And Q1 2026 Outlook Will Support Measured Upside
Analysts have lifted Marex Group's price target from $50.29 to $55.00 as they now factor in a higher profit margin of about 20.9% and a lower future P/E of roughly 9.7, despite softer revenue growth assumptions and a slightly higher discount rate. What's in the News Marex Group issued earnings guidance for the first quarter ended March 31, 2026, with expected revenues in a range of $667 million to $697 million, compared with Q1 2025 revenues of $467 million (Key Developments).
Uppdatering av berättelse • Apr 22
MRX: Higher Fair Value And Lower Future P/E Will Support Upside
Analysts have lifted their fair value estimate for Marex Group from $61.00 to $66.00, citing updated assumptions for modest positive revenue growth, a slightly higher profit margin, and a lower future P/E of 11.40 compared with the prior 13.35. What's in the News Marex Group issued earnings guidance for the quarter ending March 31, 2026, with expected revenues in a range of $667 million to $697 million, compared with Q1 2025 revenues of $467 million (Key Developments).
Uppdatering av berättelse • Apr 07
MRX: Rich Earnings Multiple Will Face Test From Softer Revenue Outlook
Analysts have inched their price targets for Marex Group higher by a few dollars into the mid $40s, reflecting updated views on revenue trends, margins, and a lower forward P/E assumption in recent TD Cowen, Piper Sandler, and Barclays research. Analyst Commentary Recent research reflects a mixed tone, with some optimism on Marex Group's revenue and margin outlook, alongside more cautious views on where the shares should trade relative to sector peers.Uppdatering av berättelse • Mar 24
MRX: Volatility And Trading Volumes Will Test Fairly Priced Shares
Analysts have lifted their average price target on Marex Group by mid single digits. Recent moves include $7 and $5 increases, citing updated assumptions for revenue trends, profit margins, and a lower implied future P/E multiple despite a slightly higher discount rate.Uppdatering av berättelse • Mar 09
MRX: Higher Trading Volumes And Supportive P/E Will Drive Future Upside
Analysts have lifted their average price target on Marex Group to $61, citing updated views on revenue trajectory, profit margins, and a modestly higher future P/E multiple informed by recent Street research revisions from TD Cowen, Piper Sandler, and Barclays. Analyst Commentary Bullish analysts are leaning into Marex Group's execution by lifting their individual price targets, which helps explain the higher Street average.Uppdatering av berättelse • Feb 23
MRX: Rising Trading Volumes And Volatility Will Support Earnings Power
Narrative update on Marex Group Analysts have nudged their Marex Group price targets higher by $7 and $5 in recent updates, while one cut a target by $1 to $49. These changes reflect adjusted views on volumes, volatility, and earnings potential rather than a change to our $61 fair value estimate.Uppdatering av berättelse • Feb 07
MRX: Higher Volatility And Volumes Will Support Earnings Power Going Forward
The analyst price target for Marex Group has increased from $56 to $61, with analysts citing updated views on revenue trends, profit margins, and future P/E assumptions reflected in recent research from TD Cowen, Piper Sandler, and Barclays. Analyst Commentary Recent research updates show bullish analysts lifting their fair value estimates for Marex Group, with the latest round of work incorporating refreshed views on revenue trends, margin resilience, and P/E assumptions.Uppdatering av berättelse • Jan 23
MRX: US Expansion And Higher Trading Volumes Will Support Future Upside
Analysts have raised their price targets on Marex Group, reflecting a revised fair value estimate from $47.71 to $50.29 as they factor in updated expectations around volumes, revenue trends, margins, and future P/E assumptions following recent sector research. Analyst Commentary Recent research updates on Marex Group show a mix of optimism and caution as analysts refresh their models ahead of upcoming results and sector comparisons.Uppdatering av berättelse • Jan 08
MRX: Rising Trading Activity Will Support Earnings Power Despite Slight Price Trim
Analysts have trimmed their price target on Marex Group to US$49 from US$50, citing refreshed views on sector volumes and volatility while keeping fair value and key valuation inputs broadly unchanged. Analyst Commentary Bullish analysts are treating the lower US$49 price target as a fine tuning rather than a reset, keeping their broader view on Marex Group intact while they refresh assumptions for sector activity.Uppdatering av berättelse • Dec 23
MRX Will Benefit From Expanding US Structured Products And Margin Resilience
Analysts have trimmed their price target on Marex Group by 4 percent to $56.00, citing slightly higher discount rates and weaker revenue growth expectations, partly offset by improved profit margin forecasts and a more attractive forward earnings multiple. What's in the News Marex Group launched a US structured products business targeting RIAs, broker dealers, and private banks.Uppdatering av berättelse • Dec 09
MRX: US Expansion Will Drive Future Upside Despite Pending Securities Lawsuits
Narrative Update on Marex Group Price Target Analysts have modestly reduced their averaged price target on Marex Group from approximately $49.00 to about $47.70. This reflects slightly weaker top line growth assumptions, partially offset by expectations for improved profit margins and a marginally lower future price to earnings multiple.Uppdatering av berättelse • Nov 25
MRX: Diversified US Expansion Will Drive Recovery Despite Securities Lawsuit Risk
Analysts have raised their price target for Marex Group from $47.67 to $49.00, citing updated assumptions around profit margins and discount rates, which support a modestly higher valuation. What's in the News Marex Group has launched its structured products business in the United States, led by Scott Kerbel.Uppdatering av berättelse • Nov 06
MRX: Revenue Outlook Will Support Rebound Despite Ongoing Class Action Lawsuits
Analysts have made a minor upward adjustment to the price target for Marex Group, now set at $47.67. This change is based on slight improvements in the revenue growth outlook and a stable discount rate.Uppdatering av berättelse • Oct 23
Analysts Lower Marex Group Price Target Amid Accounting Allegations and Revised Profit Outlook
Analysts have slightly lowered their price target for Marex Group from $49.33 to $47.67. This change reflects recent updates to the company’s growth and profitability outlook.Uppdatering av berättelse • Oct 08
Digitalization And M&A Will Unlock Global Market Potential
Analysts have lowered their price target for Marex Group from $50.89 to $49.33, citing slightly reduced profit margin forecasts and modestly improved revenue growth projections. What's in the News NINGI Research disclosed a short position in Marex Group, alleging the company used opaque off-balance-sheet entities, fictitious transactions, and misleading disclosures to obscure losses and inflate profits (Periodical).Analysartikel • Aug 06
Here's Why Marex Group (NASDAQ:MRX) Has Caught The Eye Of Investors
NasdaqGS:MRX 1 Year Share Price vs Fair Value Explore Marex Group's Fair Values from the Community and select yours...
Ny berättelse • Apr 27
Acquisitions Will Fuel APAC And Middle East Expansion
Strong market share gains and acquisition integration are driving revenue growth and expanding product offerings and geographic reach.Analysartikel • Apr 10
Further Upside For Marex Group plc (NASDAQ:MRX) Shares Could Introduce Price Risks After 26% Bounce
Marex Group plc ( NASDAQ:MRX ) shareholders have had their patience rewarded with a 26% share price jump in the last...Analysartikel • Dec 25
Many Still Looking Away From Marex Group plc (NASDAQ:MRX)
When close to half the companies in the United States have price-to-earnings ratios (or "P/E's") above 19x, you may...Fördelning av intäkter och kostnader
Fördelning av intäkter och kostnader
Hur Marex Group tjänar och spenderar pengar. Baserat på senast rapporterade resultat, på rullande tolvmånadersbasis.
Resultat- och intäktshistorik
| Datum | Intäkter | Intäkter | G+A Kostnader | FoU-kostnader |
|---|---|---|---|---|
| 31 Mar 26 | 3,266 | 334 | 1,386 | 0 |
| 31 Dec 25 | 2,870 | 294 | 1,250 | 0 |
| 30 Sep 25 | 2,668 | 266 | 1,156 | 0 |
| 30 Jun 25 | 2,608 | 251 | 1,105 | 0 |
| 31 Mar 25 | 2,530 | 234 | 1,052 | 0 |
| 31 Dec 24 | 2,357 | 205 | 990 | 0 |
| 30 Sep 24 | 2,142 | 189 | 939 | 0 |
| 30 Jun 24 | 1,883 | 134 | 1,283 | 0 |
| 31 Mar 24 | 1,849 | 140 | 1,028 | 0 |
| 31 Dec 23 | 1,882 | 128 | 799 | 0 |
| 30 Sep 23 | 1,092 | 140 | 737 | 0 |
| 30 Jun 23 | 1,818 | 139 | 451 | 0 |
| 31 Mar 23 | 1,570 | 115 | 451 | 0 |
| 01 Jan 23 | 1,010 | 92 | 459 | 0 |
| 01 Jan 22 | 825 | 57 | 371 | 0 |
| 31 Dec 20 | 758 | 44 | 277 | 0 |
| 31 Dec 19 | 549 | 36 | 212 | 0 |
| 31 Dec 18 | 384 | 10 | 0 | 0 |
| 31 Dec 17 | 318 | 18 | 0 | 0 |
| 31 Dec 16 | 328 | 20 | 0 | 0 |
| 31 Dec 15 | 346 | 18 | 0 | 0 |
Kvalitetsintäkter: MRX har inkomster av hög kvalitet.
Växande vinstmarginal: MRX s nuvarande netto vinstmarginaler (10.2%) är högre än förra året (9.2%).
Fritt kassaflöde vs resultatanalys
Analys av tidigare vinsttillväxt
Resultatutveckling: MRX s intäkter har ökat markant med 34.9% per år under de senaste 5 åren.
Accelererande tillväxt: MRX s intäktstillväxt under det senaste året ( 42.9% ) överstiger sitt 5-åriga genomsnitt ( 34.9% per år).
Resultat vs industri: MRX vinsttillväxt under det senaste året ( 42.9% ) översteg Capital Markets branschen 38.3%.
Avkastning på eget kapital
Hög ROE: Medan MRX s avkastning på eget kapital ( 25.82% ) är hög, är detta mått skevt på grund av deras höga skuldnivå.
Avkastning på tillgångar
Avkastning på sysselsatt kapital
Upptäck starka bolag som tidigare presterat bra
Företagsanalys och finansiella data Status
| Uppgifter | Senast uppdaterad (UTC-tid) |
|---|---|
| Analys av företag | 2026/06/10 11:56 |
| Aktiekurs vid dagens slut | 2026/06/10 00:00 |
| Intäkter | 2026/03/31 |
| Årlig intjäning | 2025/12/31 |
Datakällor
Den data som används i vår företagsanalys kommer från S&P Global Market Intelligence LLC. Följande data används i vår analysmodell för att generera denna rapport. Data är normaliserade vilket kan medföra en fördröjning från det att källan är tillgänglig.
| Paket | Uppgifter | Tidsram | Exempel US-källa |
|---|---|---|---|
| Företagets finansiella ställning | 10 år |
| |
| Analytikernas konsensusuppskattningar | +3 år |
|
|
| Marknadspriser | 30 år |
| |
| Ägarskap | 10 år |
| |
| Förvaltning | 10 år |
| |
| Viktiga utvecklingstendenser | 10 år |
|
* Exempel för amerikanska värdepapper, för icke-amerikanska värdepapper används motsvarande regelverk och källor.
Om inget annat anges är all finansiell data baserad på en årsperiod men uppdateras kvartalsvis. Detta kallas data för efterföljande tolv månader (TTM) eller senaste tolv månader (LTM). Lär dig mer om detta.
Analysmodell och snöflinga
Detaljer om analysmodellen som användes för att skapa den här rapporten finns på vår Github-sida, vi har också guider om hur du använder våra rapporter och tutorials på Youtube.
Lär dig mer om det team i världsklass som utformade och byggde analysmodellen Simply Wall St.
Industri- och sektormått
Våra bransch- och sektionsmått beräknas var sjätte timme av Simply Wall St, detaljer om vår process finns tillgängliga på Github.
Källor för analytiker
Marex Group plc bevakas av 11 analytiker. 7 av dessa analytiker lämnade de uppskattningar av intäkter eller resultat som användes som indata till vår rapport. Analytikernas inskickade estimat uppdateras löpande under dagen.
| Analytiker | Institution |
|---|---|
| Benjamin Budish | Barclays |
| Christopher Allen | Citigroup Inc |
| Alexander Blostein | Goldman Sachs |